CERENOVUS Neurothrombectomy Devices Registry

(EXCELLENT Trial)

Recruiting in Palo Alto (17 mi)

+39 other locations

Overseen by Raul G Nogueira, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?

A post-market registry evaluating the EmboTrap® Revascularization Device and CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.

Eligibility Criteria

Inclusion Criteria

Age ≥ 18

The participant or the participant's legally authorized representative has signed and dated an Informed Consent Form. In the event that local regulations allow for alternative approaches of consent, these must be fulfilled as approved by the sponsor and site's ethics committee/regulatory authority (if applicable)

Participants experiencing acute ischemic stroke with angiographic confirmation of Large Vessel Occlusion (LVO)

Participant Groups

Group I: Mechanical Thrombectomy Experimental Treatment 2 Interventions

EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Oregon Health & Science University Portland, OR

Washington University in St. Louis Saint Louis, MO

University of Tennessee Medical Center Knoxville, TN

TNVI Knoxville, TN

More Trial Locations

Who Is Running the Clinical Trial?

Cerenovus, Part of DePuy Synthes Products, Inc. Lead Sponsor

References